News | Radiology Imaging | November 13, 2018

Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants

Awards to five individuals will fund major research in the radiologic sciences

Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants

November 13, 2018 — The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the five recipients of its joint research grants with Canon Medical Systems USA for 2018. The 2018 Canon Medical Systems USA/RSNA Research Seed Grants were awarded to Pedram Heidari, M.D., Prashant Nagpal, M.D., and Adam Singer, M.D. The 2018 Canon Medical Systems USA Research Medical Student Grants went to Brandon Kenneth-Kouso Fields, BA, BM, and Anthony D. Yao, BS. These grants are made possible by Canon Medical Systems USA’s support of the RSNA R&E Foundation.

The Canon Medical Systems USA/RSNA Research Seed Grant provides $40,000 for a one-year project to test hypotheses and obtain pilot data in preparation for major grant applications:

  • Pedram Heidari, M.D., Massachusetts General Hospital, will investigate a novel positron emission tomography (PET) probe for imaging of disease activity in inflammatory bowel disease (IBD) in mouse models. This PET probe is specific for granzyme B which is an important marker of T cell activation involved in pathogenies of IBD. Clinical translation of this imaging method, if successful, could potentially improve management and treatment of IBD;
  • Prashant Nagpal, M.D., University of Iowa, with scientific advisor Mathews Jacob, Ph.D., will investigate whether 3-D self-navigated free-breathing cardiac magnetic resonance (CMR) sequences using manifold reconstruction algorithms compare well with the standard of care breath-held CMR sequences for patients with chronic obstructive pulmonary disease (COPD). If successful, this free-breathing CMR technique will allow high-quality comprehensive imaging in patients that cannot hold their breath; and
  • Adam Singer, M.D., Emory University, will compare the performance of a novel sonographic scoring and reporting system to MRI for soft tissue sarcoma resection bed surveillance. If sonographic diagnostic accuracy is non-inferior to MRI, it could provide a more cost effective surveillance alternative particularly when MRI is contraindicated or degraded by artifacts.

The Canon Medical Systems USA/RSNA Research Medical Student Grant provides a $3,000 stipend, matched by the department for a total of $6,000 to pursue a research project in the radiologic sciences:

  • Brandon Kenneth-Kouso “K.K.” Fields, BA, BM, University of Southern California, with scientific advisor George R. Matcuk Jr., M.D., will investigate the role of quantitative whole tumor volume MRI as a novel biomarker in evaluating response to neoadjuvant chemotherapy and radiation therapy in soft-tissue sarcomas. The principles developed with this project may lend new insight into early observable changes seen in this heterogeneous class of tumors to more accurately guide clinical management; and
  • Anthony D. Yao, B.S., Rhode Island Hospital, with scientific advisor Ryan A. McTaggart, M.D., will investigate whether artificial intelligence can assist in the imaging of emergent large vessel occlusions (ELVOs) on computed tomography (CT) angiograms. If successful, neural networks may be implemented to aid radiologists in decreasing diagnostic time and improving patient outcomes.

The RSNA R&E Foundation Board of Trustees approved funding for $4 million in radiology research and education grants this year, achieving a funding rate of 35 percent of grant applicants. “The R&E Foundation is grateful for Canon Medical Systems USA’s support of the 2018 grant recipients. This longstanding partnership and commitment is a vital component in ensuring research innovation and seeding the future of radiology,” said N. Reed Dunnick, M.D., chair of the R&E Foundation Board of Trustees.

For more information: www.rsna.org/foundation, www.us.medical.canon

Related Content

Kaplan-Meier curves for all-cause mortality in patients with versus without myocardial injury (Panel A) and in patients with versus without myocardial injury according to the presence or absence of major echocardiographic abnormalities (Panel B). *Includes wall motion abnormalities, global left ventricular dysfunction, diastolic dysfunction, right ventricular dysfunction and presence of pericardial effusion. Event rates are censored at 20 days from hospital admission. Images courtesy of Mount Sinai Health S

Kaplan-Meier curves for all-cause mortality in patients with versus without myocardial injury (Panel A) and in patients with versus without myocardial injury according to the presence or absence of major echocardiographic abnormalities (Panel B). *Includes wall motion abnormalities, global left ventricular dysfunction, diastolic dysfunction, right ventricular dysfunction and presence of pericardial effusion. Event rates are censored at 20 days from hospital admission. Images courtesy of Mount Sinai Health System

News | Ultrasound Imaging | October 28, 2020
October 28, 2020 — Card...
A sonographer at Northwestern Memorial Hospital using the Caption Health AI to optimize ultrasound imaging.

A sonographer at Northwestern Memorial Hospital using the Caption Health AI to optimize ultrasound imaging.

News | Ultrasound Imaging | October 28, 2020
October 28, 2020 — Northwestern Memorial Hospital is the first hospital in the United States to purchase Caption Heal
Chest X-ray from a patient included in the study. Posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.

Chest X-ray from a patient included in the study. Posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.

Feature | Magnetic Resonance Imaging (MRI) | October 27, 2020
October 27, 2020 – Magn...
"Initial report of a randomized trial comparing conventional- vs conventional plus fluciclovine (18F) PET/CT imaging-guided post-prostatectomy radiotherapy for prostate cancer" was presented by Ashesh Jani, M.D., Winship Cancer Institute of Emory University, at ASTRO20
News | PET Imaging | October 26, 2020
October 26, 2020 — Adding the advanced PET radiotracer...
Ceiling-mounted X-ray system includes MyExam Companion intelligent user interface to guide technologist through exam workflow
News | X-Ray | October 26, 2020
October 26, 2020 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the...
Nearly 40 MRIdian-focused presentations will be part of the ASTRO Scientific Sessions
News | Magnetic Resonance Imaging (MRI) | October 26, 2020
October 26, 2020 — ViewRay, Inc. announced that the company's MRIdian Linac MRI-guided radiation therapy system will
Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases, suggests a new study from Penn Medicine. In a retrospective trial of more than 200 patients, mini-strokes were significantly less common among patients who underwent proton therapy versus conventional photon-based radiation therapy. Proton therapy patients also experienced fewer heart attacks.
News | Proton Therapy | October 25, 2020
October 25, 2020 — Treating lung cancer patients with prot...
Radiation Oncology Orchestrator (IntelliSpace Radiation Oncology) and Practice Management can reduce the time from patient referral to the start of treatment by up to half
News | Radiation Oncology | October 25, 2020
October 25, 2020 —Philips, a global leader in health technology, will showcase its latest advances in ...